SHOC2 and liver cancer: Although we demonstrated here, for the first time, that SHOC2 acts as either an oncogene or a tumor suppressor by differentially regulating the MAPK and mTORC1 signals, using multiple liver cancer cell culture models and two liver tumorigenesis models, our study bears some limitations.